Pulse Biosciences (PLSE) FCF Margin (2021 - 2025)

Pulse Biosciences (PLSE) posted quarterly FCF Margin of 15377.91% for Q3 2025, down 211.25% quarter-over-quarter from 4940.75% in Q2 2022.

Pulse Biosciences (PLSE) FCF Margin (2021 - 2025) Analysis & Trends

Pulse Biosciences' FCF Margin history runs 3 years deep, the most recent figure standing at 15377.91% for Q3 2025.

In Q3 2025, FCF Margin changed N/A year-over-year to 15377.91%; the TTM figure through Sep 2025 stood at 56688.37% (changed N/A YoY), while the FY2022 annual figure was 6773.43%, down 290743.0% from the prior year.
FCF Margin for Q3 2025 stood at 15377.91%, down from 4940.75% in the prior quarter.
The five-year high for FCF Margin was 1503.39% in Q4 2021, with the low at 15377.91% in Q3 2025.
The 3-year median for FCF Margin is 3518.24% (2022), against an average of 5538.69%.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	FCF Margin (Qtr)
1	Intuitive Surgical	134.33 Bn	129.12 Bn	1.96 Bn	32.79%
2	Becton Dickinson	52.48 Bn	51.62 Bn	2.32 Bn	12.70%
3	Alcon	35.71 Bn	34.35 Bn	1.68 Bn	4.82%
4	Resmed	33.69 Bn	32.22 Bn	861.22 Mn	27.57%
5	Medline	29.16 Bn	26.48 Bn	2.22 Bn	7.86%
6	West Pharmaceutical Services	25.04 Bn	24.61 Bn	329.20 Mn	9.26%
7	Solventum	15.41 Bn	15.01 Bn	1.29 Bn	6.52%
8	Cooper Companies	14.79 Bn	14.65 Bn	735.40 Mn	8.91%
9	Baxter International	13.59 Bn	11.44 Bn	1.03 Bn	6.11%
10	Pulse Biosciences	3.44 Bn	3.44 Bn	161,000.00	-

Download Data